#chr	start	end	ref	obs	genotype	snp_q	depth	map_q	variant	variant_frequency	region	gene	variant_details	coding_and_splicing_details	1000g_2012feb_all	dbSNP_137	ljb_phylop	ljb_mt	esp6500si_ea	cosmic61	repeatmasker	OMIM	omim_titles	omim_disorders	quality_filter	ihdb_hom_13	ihdb_het_13	ihdb_wt_13	ihdb_allsys	classification	validated
chr1	155205047	155205047	C	T	het	225	728	37	SNV	0.5084	exonic	GBA	nonsynonymous SNV	GBA:NM_001171812:exon9:c.G1297A:p.D433N,GBA:NM_001005741:exon11:c.G1444A:p.D482N,GBA:NM_001005742:exon11:c.G1444A:p.D482N,GBA:NM_000157:exon10:c.G1444A:p.D482N,GBA:NM_001171811:exon9:c.G1183A:p.D395N,	0.0014	rs75671029	0.1614	0.9521				606463	Glucosidase, acid beta	Gaucher disease, type I, 230800(3); Gaucher disease, type II, 230900(3); Gaucher disease, type III, 231000 (3); Gaucher disease, type IIIC, 231005 (3); Gaucher disease, perinatal lethal, 608013 (3)	passed	0	0	1	0		
chr2	198362018	198362018	T	C	hom	222	538	37	SNV	1	exonic	HSPD1	synonymous SNV	HSPD1:NM_199440:exon3:c.A273G:p.K91K,HSPD1:NM_002156:exon3:c.A273G:p.K91K,	0.66	rs8539			0.6842			118190	Heat-shock 60kD protein 1	Spastic paraplegia-13, 605280 (3); Leukodystrophy, hypomyelinating,4, 612233 (3)	passed	0.2308	0.6923	0.0769	80		
chr2	202575821	202575821	G	A	hom	222	503	37	SNV	1	exonic	ALS2	synonymous SNV	ALS2:NM_020919:exon26:c.C4015T:p.L1339L,	0.91	rs3219168			0.9205			606352	Alsin	Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primarylateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	passed	0.6154	0.3846	0	81		
chr2	202598113	202598113	C	T	hom	222	780	37	SNV	0.9961	exonic	ALS2	synonymous SNV	ALS2:NM_020919:exon13:c.G2466A:p.V822V,	0.43	rs2276615			0.6033			606352	Alsin	Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primarylateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	passed	0.0769	0.3846	0.5385	64		
chr2	202625615	202625615	C	T	hom	222	982	37	SNV	1	exonic	ALS2	nonsynonymous SNV	ALS2:NM_001135745:exon4:c.G1102A:p.V368M,ALS2:NM_020919:exon4:c.G1102A:p.V368M,	0.90	rs3219156	0.0032	0.0000	0.8984			606352	Alsin	Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primarylateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	passed	0.3846	0.6154	0	82		
chr2	241680802	241680802	G	A	het	225	761	37	SNV	0.5106	intronic	KIF1A			0.28	rs56024577			0.2506						passed	0.0769	0.2308	0.6923	28		
chr2	241700676	241700676	G	A	het	225	405	37	SNV	0.5391	exonic	KIF1A	synonymous SNV	KIF1A:NM_004321:exon22:c.C2208T:p.A736A,KIF1A:NM_001244008:exon24:c.C2235T:p.A745A,	0.02	rs35945835			0.0523						passed	0	0.3846	0.6154	9		TP
chr2	241713646	241713646	A	G	het	225	657	37	SNV	0.5238	exonic	KIF1A	synonymous SNV	KIF1A:NM_004321:exon11:c.T991C:p.L331L,KIF1A:NM_001244008:exon12:c.T991C:p.L331L,	0.50	rs1063353			0.3466						passed	0.3077	0.5385	0.1538	37		
chr3	33055721	33055721	A	G	hom	222	1032	37	SNV	1	exonic	GLB1	nonsynonymous SNV	GLB1:NM_000404:exon15:c.T1561C:p.C521R,GLB1:NM_001079811:exon15:c.T1471C:p.C491R,GLB1:NM_001135602:exon12:c.T1168C:p.C390R,	0.94	rs4302331	0.1686	0.0000	0.9982			611458	Galactosidase, beta-1	GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II,230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	passed	1	0	0	137		
chr3	33138544	33138544	A	G	hom	222	28	37	SNV	1	exonic	GLB1	synonymous SNV	GLB1:NM_000404:exon1:c.T34C:p.L12L,GLB1:NM_001135602:exon1:c.T34C:p.L12L,	0.93	rs7614776			0.8855			611458	Galactosidase, beta-1	GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II,230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	passed	0.7692	0.1538	0.0769	138	1	
chr3	33138549	33138549	G	A	het	177	28	37	SNV	0.4286	exonic	GLB1	nonsynonymous SNV	GLB1:NM_000404:exon1:c.C29T:p.P10L,GLB1:NM_001135602:exon1:c.C29T:p.P10L,	0.47	rs7637099	0.1828	0.0008	0.6236			611458	Galactosidase, beta-1	GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II,230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	passed	0.2308	0.5385	0.2308	114	1	
chr3	193355074	193355074	T	C	het	225	254	37	SNV	0.4881	splicing	OPA1		OPA1(NM_130831:exon7:c.762+4T>C,NM_130834:exon9:c.924+4T>C,NM_130837:exon10:c.1035+4T>C,NM_130836:exon9:c.981+4T>C,NM_130835:exon9:c.927+4T>C,NM_130832:exon8:c.816+4T>C,NM_015560:exon8:c.870+4T>C,NM_130833:exon8:c.873+4T>C)	0.91	rs166850			0.8263			605290	Optic atrophy 1 gene	Optic atrophy 1, 165500 (3); {Glaucoma, normal tension,susceptibility to}, 606657 (3); Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, 125250 (3)	passed	0.7692	0.2308	0	131		
chr5	138456815	138456815	T	C	hom	222	553	37	SNV	1	exonic	SIL1	synonymous SNV	SIL1:NM_022464:exon3:c.A153G:p.T51T,SIL1:NM_001037633:exon4:c.A153G:p.T51T,	0.43	rs3088052			0.4308			608005	Sil1, S. cerevisiae, homolog of	Marinesco-Sjogren syndrome, 248800 (3)	passed	0.2308	0.6923	0.0769	95		
chr6	110053824	110053824	-	TT	het	33.5	280	38	INDEL	0	intronic	FIG4										609390	SAC domain-containing inositol phosphatase Fig4, S. cerevisiae,	Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateralsclerosis 11, 612577 (3)	failed	0	0	1	2		
chr6	110107517	110107517	T	C	hom	222	830	37	SNV	1	exonic	FIG4	nonsynonymous SNV	FIG4:NM_014845:exon18:c.T1961C:p.V654A,	0.37	rs9885672	0.7629	0.0002	0.1517			609390	SAC domain-containing inositol phosphatase Fig4, S. cerevisiae,	Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateralsclerosis 11, 612577 (3)	passed	0	0.1538	0.8462	27		
chr6	110146303	110146303	G	A	hom	222	1524	37	SNV	1	exonic	FIG4	synonymous SNV	FIG4:NM_014845:exon23:c.G2559A:p.S853S,	0.39	rs1127771			0.4103			609390	SAC domain-containing inositol phosphatase Fig4, S. cerevisiae,	Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateralsclerosis 11, 612577 (3)	passed	0	0.8462	0.1538	65		
chr9	135202829	135202829	T	C	hom	222	598	37	SNV	1	exonic	SETX	nonsynonymous SNV	SETX:NM_015046:exon10:c.A4156G:p.I1386V,	0.59	rs543573	0.1524	0.0000	0.8457			608465	Senataxin	Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis4, juvenile, 602433 (3)	passed	0.6154	0.3846	0	132		
chr9	135203231	135203231	C	T	hom	222	824	37	SNV	1	exonic	SETX	stopgain SNV	SETX:NM_015046:exon10:c.G3754A:p.G1252R,	0.59	rs1183768	0.9991	0.7170	0.8450			608465	Senataxin	Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis4, juvenile, 602433 (3)	passed	0.6154	0.3846	0	117	3	
chr9	135203409	135203409	A	C	hom	222	656	37	SNV	1	exonic	SETX	nonsynonymous SNV	SETX:NM_015046:exon10:c.T3576G:p.D1192E,	0.66	rs1185193	0.0031	0.0006	0.8617			608465	Senataxin	Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis4, juvenile, 602433 (3)	passed	0.6154	0.3846	0	127		
chr9	135206460	135206460	A	G	hom	222	563	37	SNV	1	exonic	SETX	synonymous SNV	SETX:NM_015046:exon9:c.T1077C:p.Y359Y,	0.65	rs9411449			0.8466			608465	Senataxin	Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis4, juvenile, 602433 (3)	passed	0.6154	0.3846	0	129	4	
chr10	13151224	13151224	G	A	het	225	142	37	SNV	0.6087	exonic	OPTN	synonymous SNV	OPTN:NM_001008211:exon4:c.G102A:p.T34T,OPTN:NM_001008213:exon4:c.G102A:p.T34T,OPTN:NM_001008212:exon3:c.G102A:p.T34T,OPTN:NM_021980:exon2:c.G102A:p.T34T,	0.18	rs2234968			0.2744	ID=COSM146881;OCCURENCE=1(stomach)					passed	0.0769	0.3846	0.5385	33		
chr10	13158262	13158262	C	T	hom	222	887	37	SNV	0.9974	intronic	OPTN			0.80	rs2244380			0.8220						passed	0.4615	0.4615	0.0769	56		
chr10	13166076	13166076	A	G	hom	222	470	37	SNV	1	exonic	OPTN	nonsynonymous SNV	OPTN:NM_001008211:exon10:c.A964G:p.K322E,OPTN:NM_001008213:exon10:c.A964G:p.K322E,OPTN:NM_001008212:exon9:c.A964G:p.K322E,OPTN:NM_021980:exon8:c.A964G:p.K322E,	0.99	rs523747	0.9963	0.0000	0.9988						passed	1	0	0	55		
chr10	99498234	99498234	G	A	hom	222	562	37	SNV	0.9964	UTR5	ZFYVE27			0.46	rs3818876			0.6121						passed	0.3846	0.5385	0.0769	39		
chr10	99504630	99504630	G	T	hom	222	597	37	SNV	1	exonic	ZFYVE27	nonsynonymous SNV	ZFYVE27:NM_001174121:exon2:c.G119T:p.G40V,ZFYVE27:NM_001002261:exon3:c.G413T:p.G138V,ZFYVE27:NM_001174119:exon3:c.G317T:p.G106V,ZFYVE27:NM_001002262:exon4:c.G413T:p.G138V,ZFYVE27:NM_144588:exon4:c.G413T:p.G138V,	0.71	rs10882993	0.9002	0.0000	0.7620						passed	0.4615	0.4615	0.0769	53		
chr11	2190925	2190925	C	T	het	225	792	37	SNV	0.5682	exonic	TH	synonymous SNV	TH:NM_199293:exon3:c.G348A:p.R116R,TH:NM_000360:exon2:c.G267A:p.R89R,TH:NM_199292:exon3:c.G360A:p.R120R,	0.0046	rs76240471			0.0054			191290	Tyrosine hydroxylase	Segawa syndrome, recessive, 605407 (3)	passed	0	0	1	1		
chr11	2190951	2190951	C	T	het	225	628	37	SNV	0.4087	exonic	TH	nonsynonymous SNV	TH:NM_199293:exon3:c.G322A:p.V108M,TH:NM_000360:exon2:c.G241A:p.V81M,TH:NM_199292:exon3:c.G334A:p.V112M,	0.42	rs6356	0.1472	0.3488	0.3630			191290	Tyrosine hydroxylase	Segawa syndrome, recessive, 605407 (3)	passed	0.0769	0.4615	0.4615	73		
chr12	110238487	110238487	A	G	het	225	332	37	SNV	0.5791	exonic	TRPV4	synonymous SNV	TRPV4:NM_001177431:exon5:c.T687C:p.D229D,TRPV4:NM_021625:exon5:c.T789C:p.D263D,TRPV4:NM_147204:exon4:c.T789C:p.D263D,	0.13	rs3742034			0.0850			605427	Transient receptor potential cation channel, subfamily V, member 4	Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinalmuscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3)	passed	0	0.3846	0.6154	18		
chr12	110240838	110240838	T	G	het	225	1004	37	SNV	0.4852	exonic	TRPV4	synonymous SNV	TRPV4:NM_001177431:exon4:c.A568C:p.R190R,TRPV4:NM_021625:exon4:c.A670C:p.R224R,TRPV4:NM_147204:exon3:c.A670C:p.R224R,TRPV4:NM_001177428:exon3:c.A670C:p.R224R,TRPV4:NM_001177433:exon3:c.A670C:p.R224R,	0.71	rs3825394			0.5274			605427	Transient receptor potential cation channel, subfamily V, member 4	Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinalmuscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3)	passed	0.3077	0.5385	0.1538	63		
chr13	23907677	23907677	C	T	hom	222	696	37	SNV	0.9986	exonic	SACS	synonymous SNV	SACS:NM_014363:exon10:c.G10338A:p.Q3446Q,	0.99	rs2737701			0.9999			604490	Sacsin	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	passed	0.9231	0.0769	0	137		
chr13	23908034	23908034	A	G	het	225	422	37	SNV	0.4743	exonic	SACS	synonymous SNV	SACS:NM_014363:exon10:c.T9981C:p.A3327A,	0.35	rs2737700			0.4406			604490	Sacsin	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	passed	0.3077	0.1538	0.5385	87		
chr13	23928671	23928671	C	T	het	225	1045	37	SNV	0.4587	exonic	SACS	nonsynonymous SNV	SACS:NM_014363:exon8:c.G2080A:p.A694T,	0.01	rs17325713	0.9866	0.0028	0.0370			604490	Sacsin	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	passed	0	0.0769	0.9231	5		
chr13	23949252	23949252	G	A	het	225	509	37	SNV	0.4788	intronic	SACS			0.11	rs3751368						604490	Sacsin	Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	passed	0	0.0769	0.9231	21		
chr13	36886469	36886469	T	C	hom	222	1140	37	SNV	0.9946	exonic	SPG20	synonymous SNV	SPG20:NM_001142296:exon8:c.A1629G:p.A543A,SPG20:NM_001142295:exon7:c.A1629G:p.A543A,SPG20:NM_001142294:exon7:c.A1629G:p.A543A,SPG20:NM_015087:exon7:c.A1629G:p.A543A,	0.30	rs2274293			0.2576			607111	Spartin	Troyer syndrome, 275900 (3)	passed	0.0769	0.1538	0.7692	32		
chr14	51057727	51057727	G	A	het	189	255	37	SNV	0.5378	exonic	ATL1	synonymous SNV	ATL1:NM_181598:exon3:c.G351A:p.E117E,ATL1:NM_015915:exon3:c.G351A:p.E117E,ATL1:NM_001127713:exon4:c.G351A:p.E117E,	0.81	rs1060197			0.7288			606439	Atlastin	Spastic paraplegia-3A, 182600 (3); Neuropathy, hereditary sensory,type ID, 613708 (3)	passed	0.5385	0.3846	0.0769	76		
chr14	53513479	53513480	AG	-	hom	214	219	39	INDEL	0	UTR3	DDHD1			0.89	rs10599915			0.8404						passed	0.7692	0.0769	0.1538	45		
chr14	53529669	53529669	A	T	hom	222	445	37	SNV	1	exonic	DDHD1	synonymous SNV	DDHD1:NM_001160147:exon8:c.T1779A:p.T593T,DDHD1:NM_030637:exon7:c.T1758A:p.T586T,DDHD1:NM_001160148:exon7:c.T1758A:p.T586T,	0.84	rs4898778			0.8387						passed	0.6923	0.3077	0	47		
chr14	53619463	53619463	G	A	hom	222	527	40	SNV	0.9954	exonic	DDHD1	synonymous SNV	DDHD1:NM_001160147:exon1:c.C354T:p.H118H,DDHD1:NM_030637:exon1:c.C354T:p.H118H,DDHD1:NM_001160148:exon1:c.C354T:p.H118H,	0.76	rs2358188									passed	0.6923	0	0.3077	32		
chr14	53619480	53619480	-	GCCGCC	hom	214	502	45	INDEL	0	exonic	DDHD1	frameshift insertion	DDHD1:NM_001160147:exon1:c.336_337insGGCGGC:p.G112delinsGAA,DDHD1:NM_030637:exon1:c.336_337insGGCGGC:p.G112delinsGAA,DDHD1:NM_001160148:exon1:c.336_337insGGCGGC:p.G112delinsGAA,		rs72341148									passed	0.6923	0.2308	0.0769	38		
chr14	53619544	53619544	G	A	hom	222	417	44	SNV	1	exonic	DDHD1	synonymous SNV	DDHD1:NM_001160147:exon1:c.C273T:p.F91F,DDHD1:NM_030637:exon1:c.C273T:p.F91F,DDHD1:NM_001160148:exon1:c.C273T:p.F91F,	0.77	rs2358189			0.8378						passed	0.6923	0.3077	0	49		
chr14	68234539	68234539	T	C	hom	222	909	37	SNV	1	exonic	ZFYVE26	nonsynonymous SNV	ZFYVE26:NM_015346:exon31:c.A5672G:p.N1891S,	0.92	rs3742883	0.0238	0.0000	0.9858			612012	Zinc finger FYVE domain-containing protein 26	Spastic paraplegia 15, 270700 (3)	passed	1	0	0	84		
chr14	68252852	68252852	A	T	het	225	304	37	SNV	0.4371	exonic	ZFYVE26	nonsynonymous SNV	ZFYVE26:NM_015346:exon17:c.T3118A:p.S1040T,	0.04	rs112787369	0.7756	0.0018	0.0420			612012	Zinc finger FYVE domain-containing protein 26	Spastic paraplegia 15, 270700 (3)	passed	0.0769	0.1538	0.7692	6		
chr14	68264867	68264867	A	G	hom	222	951	37	SNV	0.9978	exonic	ZFYVE26	synonymous SNV	ZFYVE26:NM_015346:exon11:c.T2112C:p.P704P,	0.76	rs12891164			0.6415			612012	Zinc finger FYVE domain-containing protein 26	Spastic paraplegia 15, 270700 (3)	passed	0.2308	0.6154	0.1538	68		
chr14	68268838	68268838	C	T	het	225	561	37	SNV	0.4863	exonic	ZFYVE26	nonsynonymous SNV	ZFYVE26:NM_015346:exon10:c.G1597A:p.A533T,			0.9208	0.0014				612012	Zinc finger FYVE domain-containing protein 26	Spastic paraplegia 15, 270700 (3)	passed	0	0	1	0		
chr14	88401213	88401213	T	C	hom	222	645	37	SNV	1	exonic	GALC	nonsynonymous SNV	GALC:NM_001201401:exon16:c.A1852G:p.T618A,GALC:NM_000153:exon17:c.A1921G:p.T641A,GALC:NM_001201402:exon17:c.A1843G:p.T615A,	0.94	rs421262	0.0638	0.0000	0.9994			606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	1	0	0	133		
chr14	88407716	88407716	-	AA	het	160	662	37	INDEL	0	intronic	GALC										606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	0	0	1	12		
chr14	88407734	88407734	G	C	hom	222	662	37	SNV	1	intronic	GALC			0.94	rs448805			0.9993			606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	0.8462	0	0.1538	129		
chr14	88407875	88407875	T	A	hom	222	142	37	SNV	1	exonic	GALC	synonymous SNV	GALC:NM_001201401:exon14:c.A1629T:p.V543V,GALC:NM_000153:exon15:c.A1698T:p.V566V,GALC:NM_001201402:exon15:c.A1620T:p.V540V,	0.94	rs421466			0.9994			606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	1	0	0	138		
chr14	88411947	88411947	T	C	hom	222	317	37	SNV	1	exonic	GALC	synonymous SNV	GALC:NM_001201401:exon13:c.A1551G:p.T517T,GALC:NM_000153:exon14:c.A1620G:p.T540T,GALC:NM_001201402:exon14:c.A1542G:p.T514T,	0.94	rs367327			0.9994			606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	1	0	0	139		
chr14	88417096	88417096	A	-	hom	55.5	320	37	INDEL	0	splicing	GALC		GALC(NM_000153:exon12:c.1162-4T>-,NM_001201402:exon12:c.1084-4T>-,NM_001201401:exon11:c.1093-4T>-)		rs11300320						606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	1	0	0	127		
chr14	88431898	88431898	C	T	hom	222	478	37	SNV	1	exonic	GALC	synonymous SNV	GALC:NM_001201401:exon8:c.G915A:p.Q305Q,GALC:NM_000153:exon9:c.G984A:p.Q328Q,GALC:NM_001201402:exon9:c.G906A:p.Q302Q,	0.35	rs12888666			0.3482			606890	Galactosylceraminidase	Krabbe disease, 245200 (3)	passed	0	0.4615	0.5385	86		
chr15	23052632	23052632	T	C	hom	222	560	37	SNV	1	exonic	NIPA1	synonymous SNV	NIPA1:NM_144599:exon4:c.A441G:p.T147T,NIPA1:NM_001142275:exon4:c.A216G:p.T72T,	0.70	rs11263683			0.7352			608145	Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome	Spastic paraplegia-6, 600363 (3)	passed	0.3077	0.5385	0.1538	80		
chr15	51217361	51217361	T	C	het	225	1194	37	SNV	0.52	exonic	AP4E1	nonsynonymous SNV	AP4E1:NM_007347:exon5:c.T487C:p.C163R,AP4E1:NM_001252127:exon5:c.T262C:p.C88R,	0.48	rs2306331	0.9769	0.0000	0.4575			607244	Adaptor-related protein complex 4, epsilon-1 subunit	Cerebral palsy, spastic quadriplegic, 4, 613744 (3)	passed	0.6154	0.2308	0.1538	53		
chr15	51294832	51294832	G	A	het	225	486	37	SNV	0.4813	exonic	AP4E1	synonymous SNV	AP4E1:NM_007347:exon21:c.G3387A:p.Q1129Q,AP4E1:NM_001252127:exon21:c.G3162A:p.Q1054Q,	0.24	rs3825798			0.2317			607244	Adaptor-related protein complex 4, epsilon-1 subunit	Cerebral palsy, spastic quadriplegic, 4, 613744 (3)	passed	0.3077	0.4615	0.2308	34		
chr15	72637795	72637795	T	C	hom	222	1075	37	SNV	1	exonic	HEXA	synonymous SNV	HEXA:NM_000520:exon13:c.A1518G:p.E506E,	0.90	rs4777502			0.9980			606869	Hexosaminidase A, alpha polypeptide	Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms,272800 (3); [Hex A pseudodeficiency], 272800 (3)	passed	1	0	0	166		
chr15	72638892	72638892	T	C	hom	222	2012	37	SNV	1	exonic	HEXA	nonsynonymous SNV	HEXA:NM_000520:exon11:c.A1306G:p.I436V,	0.90	rs1800431	0.0013	0.0000	0.9980			606869	Hexosaminidase A, alpha polypeptide	Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms,272800 (3); [Hex A pseudodeficiency], 272800 (3)	passed	1	0	0	161		
chr16	31193942	31193942	C	A	het	225	582	37	SNV	0.523	exonic	FUS	synonymous SNV	FUS:NM_001170937:exon3:c.C147A:p.G49G,FUS:NM_004960:exon3:c.C147A:p.G49G,FUS:NM_001170634:exon3:c.C147A:p.G49G,	0.22	rs741810			0.2901			137070	Fusion, derived from 12-16 translocation, malignant liposarcoma	Amyotrophic lateral sclerosis 6, autosomal recessive, with or withoutfrontotemporal dementia, 608030 (3)	passed	0.1538	0.2308	0.6154	36		
chr16	31195279	31195279	C	T	het	225	1178	37	SNV	0.4354	exonic	FUS	synonymous SNV	FUS:NM_001170937:exon4:c.C291T:p.Y97Y,FUS:NM_004960:exon4:c.C291T:p.Y97Y,FUS:NM_001170634:exon4:c.C288T:p.Y96Y,	0.53	rs1052352			0.5549			137070	Fusion, derived from 12-16 translocation, malignant liposarcoma	Amyotrophic lateral sclerosis 6, autosomal recessive, with or withoutfrontotemporal dementia, 608030 (3)	passed	0.2308	0.5385	0.2308	64		
chr16	74750396	74750396	T	C	hom	222	1600	37	SNV	0.998	exonic	FA2H	synonymous SNV	FA2H:NM_024306:exon6:c.A888G:p.V296V,	0.13	rs11554621			0.1492			611026	Fatty acid 2-hydroxylase	Spastic paraplegia 35, autosomal recessive, 612319 (3)	passed	0	0.1538	0.8462	23		
chr16	74750405	74750405	G	A	hom	222	1603	37	SNV	1	exonic	FA2H	synonymous SNV	FA2H:NM_024306:exon6:c.C879T:p.P293P,	0.75	rs2301865			0.8055			611026	Fatty acid 2-hydroxylase	Spastic paraplegia 35, autosomal recessive, 612319 (3)	passed	0.7692	0.2308	0	82		
chr16	74808425	74808425	G	A	hom	222	992	37	SNV	0.9979	exonic	FA2H	synonymous SNV	FA2H:NM_024306:exon1:c.C229T:p.L77L,	0.26	rs929881			0.2861			611026	Fatty acid 2-hydroxylase	Spastic paraplegia 35, autosomal recessive, 612319 (3)	passed	0	0.5385	0.4615	23		
chr16	89576879	89576879	-	T	het	49.5	589	37	INDEL	0	splicing	SPG7		SPG7(NM_003119:exon2:c.184-3->T,NM_199367:exon2:c.184-3->T)								602783	Paraplegin	Spastic paraplegia-7, 607259 (3)	passed	0	0.5385	0.4615	8		
chr16	89597221	89597221	A	G	hom	222	1134	37	SNV	1	intronic	SPG7			0.52	rs4785691			0.4448			602783	Paraplegin	Spastic paraplegia-7, 607259 (3)	passed	0.0769	0.8462	0.0769	61		
chr17	42987523	42987523	G	A	het	225	662	37	SNV	0.4968	exonic	GFAP	nonsynonymous SNV	GFAP:NM_001131019:exon8:c.C1277T:p.T426M,	0.08	rs9908084			0.1669			137780	Glial fibrillary acidic protein	Alexander disease, 203450 (3)	passed	0.0769	0.2308	0.6923	24		
chr17	42987524	42987524	T	C	hom	222	662	37	SNV	1	exonic	GFAP	nonsynonymous SNV	GFAP:NM_001131019:exon8:c.A1276G:p.T426A,	0.24	rs9916491			0.2743			137780	Glial fibrillary acidic protein	Alexander disease, 203450 (3)	passed	0.0769	0.3077	0.6154	30		
chr19	7606908	7606908	G	C	het	225	851	37	SNV	0.5157	exonic	PNPLA6	nonsynonymous SNV	PNPLA6:NM_001166111:exon12:c.G1234C:p.A412P,PNPLA6:NM_001166113:exon13:c.G1090C:p.A364P,PNPLA6:NM_001166112:exon13:c.G1090C:p.A364P,PNPLA6:NM_001166114:exon10:c.G1207C:p.A403P,PNPLA6:NM_006702:exon13:c.G1090C:p.A364P,	0.12	rs17854645	0.9919	0.8115	0.2166						passed	0	0.2308	0.7692	15		
chr19	7607441	7607441	C	T	het	225	277	37	SNV	0.5336	intronic	PNPLA6			0.26	rs574930			0.3497						passed	0.0769	0.2308	0.6923	24		
chr19	7607564	7607564	T	C	hom	222	478	37	SNV	1	intronic	PNPLA6			0.71	rs620744			0.6383						passed	0.4615	0.1538	0.3846	45		
chr19	30193721	30193721	G	A	het	225	326	37	SNV	0.5144	exonic	C19orf12	synonymous SNV	C19orf12:NM_031448:exon3:c.C324T:p.T108T,C19orf12:NM_001256047:exon3:c.C324T:p.T108T,C19orf12:NM_001031726:exon3:c.C357T:p.T119T,	0.61	rs10424582			0.7441						passed	0.5385	0.4615	0	52		
chr19	46057081	46057081	A	G	hom	222	407	37	SNV	1	exonic	OPA3	synonymous SNV	OPA3:NM_025136:exon2:c.T231C:p.A77A,	0.77	rs3826860			0.6428			606580	OPA3 gene	3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophyand cataract, 165300 (3)	passed	0.4615	0.4615	0.0769	118		
chr20	3870124	3870124	G	C	hom	222	854	37	SNV	1	exonic	PANK2	nonsynonymous SNV	PANK2:NM_153638:exon1:c.G377C:p.G126A,	0.88	rs3737084	0.9816	0.0000	0.9156			606157	Pantothenate kinase 2	Neurodegeneration with brain iron accumulation 1, 234200 (3);HARP syndrome, 607236 (3)	passed	0.6923	0.3077	0	50		
chr22	38528888	38528888	C	T	het	225	1132	37	SNV	0.4894	exonic	PLA2G6	nonsynonymous SNV	PLA2G6:NM_001004426:exon7:c.G1027A:p.A343T,PLA2G6:NM_003560:exon7:c.G1027A:p.A343T,PLA2G6:NM_001199562:exon7:c.G1027A:p.A343T,	0.01	rs11570680	0.9721	0.9649	0.0128			603604	Phospholipase A2, group VI	Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegenerationwith brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)	passed	0	0	1	14		
chrX	73641252	73641252	T	G	het	7.8	621	39	SNV	0.2406	upstream	SLC16A2					0.9299	0.9999			314	300095	Solute carrier family 16 (monocarboxylic acid transporters),	Allan-Herndon-Dudley syndrome, 300523 (3)	failed	0	0.0769	0.9231	1		
chrX	153005605	153005605	G	A	het	225	453	37	SNV	0.4424	exonic	ABCD1	synonymous SNV	ABCD1:NM_000033:exon6:c.G1548A:p.L516L,	0.07	rs41314153			0.1084			300371	ATP-binding cassette, subfamily D, member 1	Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)	passed	0.2308	0	0.7692	20		
chrX	153009197	153009197	G	C	het	225	701	37	SNV	0.5368	UTR3	ABCD1			0.70	rs2229539			0.6915			300371	ATP-binding cassette, subfamily D, member 1	Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)	passed	0.7692	0.2308	0	67		